Medically reviewed by Drugs.com. Last updated on March 3, 2021.
Generic name: UBROGEPANT 50mg
Dosage form: tablet
2.1 Recommended Dosage
The recommended dose of UBRELVY is 50 mg or 100 mg taken orally with or without food.
If needed, a second dose may be taken at least 2 hours after the initial dose. The maximum dose in a 24-hour period is 200 mg. The safety of treating more than 8 migraines in a 30-day period has not been established.
2.2 Dosage Modifications
Dosing modifications for concomitant use of specific drugs and for patients with hepatic or renal impairment are provided in Table 1.
|Concomitant Drug [see Drug Interactions (7)]|
|Moderate CYP3A4 Inhibitors (7.1)||50 mg||Avoid within 24 hours|
|Weak CYP3A4 Inhibitors (7.1)||50 mg||50 mg|
|Strong CYP3A4 Inducers (7.2)||Avoid concomitant use|
|Weak & Moderate CYP3A4 Inducers (7.2)||100 mg||100 mg|
|BCRP and/or P-gp only Inhibitors (7.3)||50 mg||50 mg|
|Specific Populations [see Use in Specific Populations (8)]|
|Severe Hepatic Impairment (Child-Pugh Class C) (8.6)||50 mg||50 mg|
|Severe Renal Impairment (CLcr 15-29 mL/min) (8.7)||50 mg||50 mg|
|End-Stage Renal Disease (CLcr <15 mL/min) (8.7)||Avoid use|
a Second dose may be taken at least 2 hours after the initial dose
Frequently asked questions
- What are the new drugs for the treatment and prevention of migraine?
- What is Ubrelvy used for and how fast does Ubrelvy work?
- Ubrelvy vs Emgality: How do they compare for migraines?
- Is Ubrelvy a narcotic used for migraine?
- How do you take Ubrelvy tablets?
More about Ubrelvy (ubrogepant)
- Side Effects
- During Pregnancy or Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 109 Reviews
- Drug class: CGRP inhibitors
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.